NDC 15631-0208

GNAPHALIUM POLYCEPHALUM

Gnaphalium Polycephalum

GNAPHALIUM POLYCEPHALUM is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Pseudognaphalium Obtusifolium.

Product ID15631-0208_a144d6bf-b4ba-bccc-e053-2995a90ae2f9
NDC15631-0208
Product TypeHuman Otc Drug
Proprietary NameGNAPHALIUM POLYCEPHALUM
Generic NameGnaphalium Polycephalum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2015-10-02
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NamePSEUDOGNAPHALIUM OBTUSIFOLIUM
Active Ingredient Strength1 [hp_X]/1
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 15631-0208-0

100 PELLET in 1 PACKAGE (15631-0208-0)
Marketing Start Date2018-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0208-1 [15631020801]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0208-5 [15631020805]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0208-2 [15631020802]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0208-3 [15631020803]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0208-0 [15631020800]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

NDC 15631-0208-4 [15631020804]

GNAPHALIUM POLYCEPHALUM PELLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2018-01-01
Inactivation Date2020-01-31
Reactivation Date2020-03-20

Drug Details

Active Ingredients

IngredientStrength
PSEUDOGNAPHALIUM OBTUSIFOLIUM1 [hp_X]/1

OpenFDA Data

SPL SET ID:945d3dfc-0bbf-41bb-954e-d311a9ad215f
Manufacturer
UNII

NDC Crossover Matching brand name "GNAPHALIUM POLYCEPHALUM" or generic name "Gnaphalium Polycephalum"

NDCBrand NameGeneric Name
0220-2306Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM
0220-2307Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM
0220-2310Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM
0220-2313Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM
15631-0208GNAPHALIUM POLYCEPHALUMGNAPHALIUM POLYCEPHALUM
15631-0592GNAPHALIUM POLYCEPHALUMGNAPHALIUM POLYCEPHALUM
37662-0928Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0929Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0930Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0931Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0932Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0933Gnaphalium PolycephalumGnaphalium Polycephalum
37662-0934Gnaphalium PolycephalumGnaphalium Polycephalum
68428-409Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM
71919-321Gnaphalium polycephalumPSEUDOGNAPHALIUM OBTUSIFOLIUM

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.